Slide Deck for HealthTech Companies

HealthTech presentations are uniquely high-stakes: the regulatory landscape is complex, the clinical evidence requirements are rigorous, and the sales cycles span 12–24 months with multiple stakeholder committees. Investors who fund health technology have deep domain expertise and will probe regulatory status, evidence quality, and reimbursement strategy with precise questions. Hospital buyers have structured procurement processes that require specific certifications and clinical validation. Getting the deck structure right doesn't close deals — but getting it wrong ends conversations.

Investor Deck for Health Technology

Regulatory Pathway Clarity

The regulatory slide is the first credibility test in a healthtech investor deck. Be explicit and technical — vague regulatory statements signal that you don't understand your own regulatory position.

FDA device classification:

• Class I: general controls, exempt from 510(k) in most cases (low-risk devices: bandages, tongue depressors)
• Class II: special controls, typically requires 510(k) premarket notification (moderate risk: most digital health devices and SaMD)
• Class III: premarket approval (PMA) required — highest risk, highest regulatory burden (implantable devices, life-sustaining devices)

Clearance pathways:

• 510(k): requires demonstrating substantial equivalence to a predicate device already on the market. Average review time: 3–6 months for traditional 510(k); ~1 month for De Novo request if there's no predicate
• De Novo: for novel device types with low-to-moderate risk; creates a new regulatory classification
• PMA (Premarket Approval): clinical trial data required; 180-day review period; the highest regulatory bar

Software as a Medical Device (SaMD): the FDA's Digital Health Center of Excellence and its AI/ML action plan govern software products that perform medical functions. If your software diagnoses, treats, or makes clinical decisions, it likely meets the SaMD definition. State your software's intended use explicitly and map it to the appropriate FDA oversight level.

State your current status: cleared, approved, De Novo granted, 510(k) pending, or pre-submission meeting completed. If you're pre-submission, show your regulatory strategy and timeline.

Clinical Evidence

Health investors scrutinize evidence quality more than most VC categories — there's too much history of healthtech companies with weak evidence failing to achieve adoption after large fundraises.

Tiers of evidence, from most to least persuasive:

1. Randomized controlled trials (RCTs): gold standard; blinded where possible; published in peer-reviewed journals (NEJM, JAMA, The Lancet, or domain-specific journals)
2. Prospective cohort studies: well-designed observational studies with appropriate controls
3. Real-world evidence: PCORI-funded or otherwise rigorously designed retrospective studies; acceptable when RCTs aren't feasible
4. Case series and pilot studies: useful for early-stage; must be labeled as preliminary and not over-interpreted

Show your evidence clearly: study design, sample size, primary endpoint, result with statistical significance, and publication venue. If your evidence is weak, acknowledge it and explain the evidence generation plan with timeline.

HIPAA Compliance Architecture

For any product touching patient health information (PHI), HIPAA compliance is table stakes. Show:

• Business associate agreements (BAA) executed with all vendors in the PHI data flow
• PHI handling architecture: where PHI is stored, how it's encrypted at rest (AES-256 minimum) and in transit (TLS 1.2+), access controls, and audit logging
• SOC 2 Type II certification status — investors and hospital buyers both require this; the audit report covers security, availability, and confidentiality
• HITRUST Common Security Framework: increasingly expected for enterprise hospital sales; demonstrates alignment with HIPAA and other healthcare-specific controls

Reimbursement Strategy

The most critical and most commonly weak slide in healthtech investor decks: who pays for your product?

Reimbursement pathways:

• CPT codes: American Medical Association's Current Procedural Terminology codes. Getting an existing CPT code to cover your technology (via Category III tracking codes before Category I permanent codes) is a multi-year process but creates a clear payment pathway
• ICD-10 codes: diagnosis codes that trigger billing — your product needs to fit an existing or new ICD-10 framework
• CMS NTAP (New Technology Add-on Payment): available for FDA-approved hospital inpatient technologies that demonstrate substantial clinical improvement; provides temporary add-on payment while evidence builds for permanent DRG adjustment
• CMMI Innovation Center: Center for Medicare & Medicaid Innovation models (ACO REACH, AHEAD, etc.) that test new payment approaches — relevant for population health and care management tools
• Commercial payer contracts: direct negotiation with commercial insurers (UnitedHealth, CVS Aetna, Elevance, Humana) — requires clinical evidence and health economic data (cost-effectiveness or budget impact model)

Be explicit about your path: which payers you've contracted with, at what reimbursement rates, and your timeline to broader coverage.

EHR Integration

Epic (approximately 30% US hospital market share) and Cerner/Oracle Health (approximately 25%) dominate the US EHR market. Show:

• Epic App Orchard: certification status — this validates that your integration has been tested against Epic's APIs and meets their security standards
• SMART on FHIR: the open standard for EHR app integration; FHIR R4 (Release 4) is the current version most EHRs are implementing
• HL7 FHIR R4 compliance: bidirectional data exchange means data flows from the EHR into your product and results flow back — closing the workflow loop without requiring the clinician to leave the EHR
• CDS Hooks: for real-time clinical decision support integrated directly into the clinical workflow at the point of care

Hospital Sales Pitch Deck

Hospital procurement involves the clinical champion (physician or nursing leader), the CMO or CNO, the CIO and IT security team, the supply chain / value analysis committee, and often the CFO. Each stakeholder has different questions — your deck needs to speak to all of them.

Clinical workflow integration: hospitals reject products that add workflow steps. Show exactly where your product sits in the existing clinical workflow — ideally in a before/after workflow diagram. The fewer new clicks, the better the adoption rate.

Outcomes data: quantified clinical and operational outcomes from existing hospital customers:

• Readmission reduction (30-day readmission rate is a CMS quality measure with financial penalties)
• Length of stay (LOS) reduction
• HCAHPS improvement (Hospital Consumer Assessment of Healthcare Providers and Systems — patient satisfaction scores tied to value-based payment)
• Cost per episode of care reduction

IT security review preparation: hospital IT security reviews involve comprehensive questionnaires (often 200+ questions based on the HITRUST framework or the SIG — Standardized Information Gathering questionnaire). Having SOC 2 Type II, HITRUST, or ISO 27001 certifications dramatically shortens this process. Show which certifications you hold.

Budget pathway: distinguish capital vs. operating budget. SaaS subscription models fall under operating budget (OpEx) — typically easier to approve within the department. Capital purchases require a separate capital request process with longer cycle times. Pricing your product as OpEx is a meaningful competitive advantage.

Building HealthTech Decks in Slide-deck.io

Slide-deck.io provides clinical evidence table templates that display study design, sample size, primary endpoint, and result in a format formatted for both investor review and clinical committee evaluation. Regulatory timeline slides show the FDA pathway visually — clearance status, pending applications, and anticipated milestones.

Workflow integration diagrams show the before/after clinical workflow in a two-column format that hospital buyers can review in a committee meeting without requiring a product demo. The compliance checklist template covers HIPAA, SOC 2, HITRUST, and EHR integration status in a single slide that answers the IT security team's first-pass questions before the formal security review begins.